Improved intensive care unit survival for critically ill allogeneic haematopoietic stem cell transplant recipients following reduced intensity conditioning

British Journal of Haematology

Volumn 161, Issue 4, 2013, Pages 578-586

  Townsend, William M ^a   Holroyd, Ailsa ^a   Pearce, Rachel ^b   Mackinnon, Stephen ^c   Naik, Prakesh ^a   Goldstone, Anthony H ^a   Linch, David C ^a   Peggs, Karl S ^a   Thomson, Kirsty J ^a   Singer, Mervyn ^a   Howell, David C J ^a   Morris, Emma C ^a,d  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b British Society for Blood and Marrow Transplantation   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Allogeneic haematopoietic stem cell transplantation; Intensive care; Long term outcome; Transplant toxicity

Indexed keywords

ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; ARTIFICIAL VENTILATION; CHILD; CONTROLLED STUDY; CRITICAL ILLNESS; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; INTERMETHOD COMPARISON; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYELOABLATIVE CONDITIONING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; SURVIVAL PREDICTION;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84876790446     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12294     Document Type: Article

References (37)

1. Afessa, B., Tefferi, A., Hoagland, H.C., Letendre, L. & Peters, S.G. (1992) Outcome of recipients of bone marrow transplants who require intensive-care unit support. Mayo Clinic Proceedings, 67, 117-122.
2. Afessa, B., Tefferi, A., Dunn, W.F., Litzow, M.R. & Peters, S.G. (2003) Intensive care unit support and acute physiology and chronic health evaluation III performance in hematopoietic stem cell transplant recipients. Critical Care Medicine, 31, 1715-1721.
3. Azoulay, E., Pochard, F., Chevret, S., Vinsonneau, C., Garrouste, M., Cohen, Y., Thuong, M., Paugam, C., Apperre, C., De Cagny, B., Brun, F., Bornstain, C., Parrot, A., Thamion, F., Lacherade, J.C., Bouffard, Y., Le Gall, J.R., Herve, C., Grassin, M., Zittoun, R., Schlemmer, B. & Dhainaut, J.F. (2001) Compliance with triage to intensive care recommendations. Critical Care Medicine, 29, 2132-2136.
4. Bach, P.B., Schrag, D., Nierman, D.M., Horak, D., White, P. Jr, Young, J.W. & Groeger, J.S. (2001) Identification of poor prognostic features among patients requiring mechanical ventilation after hematopoietic stem cell transplantation. Blood, 98, 3234-3240.
5. Bacigalupo, A., Sormani, M.P., Lamparelli, T., Gualandi, F., Occhini, D., Bregante, S., Raiola, A.M., di Grazia, C., Dominietto, A., Tedone, E., Piaggio, G., Podesta, M., Bruno, B., Oneto, R., Lombardi, A., Frassoni, F., Rolla, D., Rollandi, G., Viscoli, C., Ferro, C., Garbarino, L. & Van Lint, M.T. (2004) Reducing transplant-related mortality after allogeneic hematopoietic stem cell transplantation. Haematologica, 89, 1238-1247.
6. Bernard, G.R., Vincent, J.L., Laterre, P.F., LaRosa, S.P., Dhainaut, J.F., Lopez-Rodriguez, A., Steingrub, J.S., Garber, G.E., Helterbrand, J.D., Ely, E.W. & Fisher, C.J. Jr & The Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group. (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. New England Journal of Medicine, 344, 699-709.
7. Bokhari, S.W., Munir, T., Memon, S., Byrne, J.L., Russell, N.H. & Beed, M. (2010) Impact of critical care reconfiguration and track-and-trigger outreach team intervention on outcomes of haematology patients requiring intensive care admission. Annals of Hematology, 89, 505-512.
8. Bone, R.C., Balk, R.A., Cerra, F.B., Dellinger, R.P., Fein, A.M., Knaus, W.A., Schein, R.M. & Sibbald, W.J. (2009) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest, 136(Suppl. 5), e28.
9. Brunkhorst, F.M., Engel, C., Bloos, F., Meier-Hellmann, A., Ragaller, M., Weiler, N., Moerer, O., Gruendling, M., Oppert, M., Grond, S., Olthoff, D., Jaschinski, U., John, S., Rossaint, R., Welte, T., Schaefer, M., Kern, P., Kuhnt, E., Kiehntopf, M., Hartog, C., Natanson, C., Loeffler, M. & Reinhart, K. (2008) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. New England Journal of Medicine, 358, 125-139.
10. Chakraverty, R., Peggs, K., Chopra, R., Milligan, D.W., Kottaridis, P.D., Verfuerth, S., Geary, J., Thuraisundaram, D., Branson, K., Chakrabarti, S., Mahendra, P., Craddock, C., Parker, A., Hunter, A., Hale, G., Waldmann, H., Williams, C.D., Yong, K., Linch, D.C., Goldstone, A.H. & Mackinnon, S. (2002) Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen. Blood, 99, 1071-1078.
11. Cherif, H., Martling, C.R., Hansen, J., Kalin, M. & Björkholm, M. (2007) Predictors of short and long-term outcome in patients with hematological disorders admitted to the intensive care unit for a life-threatening complication. Supportive Care in Cancer, 15, 1393-1398.
12. Cornet, A.D., Issa, A.I., van de Loosdrecht, A.A., Ossenkoppele, G.J., Strack van Schijndel, R.J. & Groeneveld, A.B. (2005) Sequential organ failure predicts mortality of patients with a haematological malignancy needing intensive care. European Journal of Haematology, 74, 511-516.
13. Craddock, C.F. (2008) Full-intensity and reduced-intensity allogeneic stem cell transplantation in AML. Bone Marrow Transplantation, 41, 415-423.
14. Darmon, M., Azoulay, E., Alberti, C., Fieux, F., Moreau, D., Le Gall, J.R. & Schlemmer, B. (2002) Impact of neutropenia duration on short-term mortality in neutropenic critically ill cancer patients. Intensive Care Medicine, 28, 1775-1780.
15. Depuydt, P.O., Benoit, D.D., Vandewoude, K.H., Decruyenaere, J.M. & Colardyn, F.A. (2004) Outcome in noninvasively and invasively ventilated hematologic patients with acute respiratory failure. Chest, 126, 1299-1306.
16. Depuydt, P., Kerre, T., Noens, L., Nollet, J., Offner, F., Decruyenaere, J. & Benoit, D. (2011) Outcome in critically ill patients with allogeneic BM or peripheral haematopoietic SCT: a single-centre experience. Bone Marrow Transplantation, 44, 1186-1191.
17. Epner, D.E., White, P., Krasnoff, M., Khanduja, S., Kimball, K.T. & Knaus, W.A. (1996) Outcome of mechanical ventilation for adults with hematologic malignancy. Journal of Investigative Medicine, 44, 254-260.
18. Faber-Langendoen, K., Caplan, A.L. & McGlave, P.B. (1993) Survival of adult bone marrow transplant patients receiving mechanical ventilation: a case for restricted use. Bone Marrow Transplantation, 12, 501-507.
19. Harrison, D.A., Brady, A.R. & Rowan, K. (2004) Case mix, outcome and length of stay for admissions to adult, general critical care units in England, Wales and Northern Ireland: the Intensive Care National Audit & Research Centre Case Mix Programme Database. Critical Care, 8, 99-111.
20. Hinds, C.J., Martin, R. & Quinton, P. (1998) Intensive care for patients with medical complications of haematological malignancy: is it worth it? Schweizerische Medizinische Wochenschrift, 128, 1467-1473.
21. Jackson, S.R., Tweeddale, M.G., Barnett, M.J., Spinelli, J.J., Sutherland, H.J., Reece, D.E., Klingemann, H.G., Nantel, S.H., Fung, H.C., Toze, C.L., Phillips, G.L. & Shepherd, J.D. (1998) Admission of bone marrow transplant recipients to the intensive care unit: outcome, survival and prognostic factors. Bone Marrow Transplantation, 21, 697-704.
22. Knaus, W.A., Draper, E.A., Wagner, D.P. & Zimmerman, J.E. (1985) APACHE II: a severity of disease classification system. Critical Care Medicine, 13, 818-829.
23. Lim, Z., Pagliuca, A., Simpson, S., Cottam, S., Ervine, M., Ho, A.Y., Devereux, S. & Mufti, G.J. (2007) Outcomes of patients with haematological malignancies admitted to intensive care unit. A comparative review of allogeneic haematopoietic stem cell transplantation data. British Journal of Haematology, 136, 448-450.
24. Martino, R., Piñana, J.L., Parody, R., Valcarcel, D., Sureda, A., Brunet, S., Briones, J., Delgado, J., Sánchez, F., Rabella, N. & Sierra, J. (2009) Lower respiratory tract respiratory virus infections increase the risk of invasive aspergillosis after a reduced-intensity allogeneic hematopoietic SCT. Bone Marrow Transplantation, 44, 749-756.
25. Morris, E.C. & Mackinnon, S. (2005) Reduced intensity allogeneic stem cell transplantation for low grade non-Hodgkin's lymphoma. Best Practice and Research in Clinical Haematology, 18, 129-142.
26. Naeem, N., Reed, M.D., Creger, R.J., Youngner, S.J. & Lazarus, H.M. (2006) Transfer of the hematopoietic stem cell transplant patient to the intensive care unit: does it really matter? Bone Marrow Transplantation, 37, 119-133.
27. Paz, H.L., Crilley, P., Weinar, M. & Brodsky, I. (1993) Outcome of patients requiring medical ICU admission following bone marrow transplantation. Chest, 104, 527-531.
28. Paz, H.L., Garland, A., Weinar, M., Crilley, P. & Brodsky, I. (1998) Effect of clinical outcomes data on intensive care unit utilization by bone marrow transplant patients. Critical Care Medicine, 26, 66-70.
29. Peggs, K.S., Kayani, I., Edwards, N., Kottaridis, P., Goldstone, A.H., Linch, D.C., Hough, R., Morris, E.C., Fielding, A., Chakraverty, R., Thomson, K.J. & Mackinnon, S. (2011) Donor lymphocyte infusions modulate relapse risk in mixed chimeras and induce durable salvage in relapsed patients after T-cell-depleted allogeneic transplantation for Hodgkin's lymphoma. Journal of Clinical Oncology, 29, 971-978.
30. Pène, F., Aubron, C., Azoulay, E., Blot, F., Thiéry, G., Raynard, B., Schlemmer, B., Nitenberg, G., Buzyn, A., Arnaud, P., Socié, G. & Mira, J.P. (2006) Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports. Journal of Clinical Oncology, 24, 643-649.
31. Price, K.J., Thall, P.F., Kish, S.K., Shannon, V.R. & Andersson, B.S. (1998) Prognostic indicators for blood and marrow transplant patients admitted to an intensive care unit. American Journal of Respiratory and Critical Care Medicine, 158, 876-884.
32. Rabe, C., Mey, U., Paashaus, M., Musch, A., Tasci, S., Glasmacher, A., Schmidt-Wolf, I.G., Sauerbruch, T. & Dumoulin, F.L. (2004) Outcome of patients with acute myeloid leukemia and pulmonary infiltrates requiring invasive mechanical ventilation-a retrospective analysis. Journal of Critical Care, 19, 29-35.
33. Rivers, E., Nguyen, B., Havstad, S., Ressler, J., Muzzin, A., Knoblich, B., Peterson, E. & Tomlanovich, M. & Early Goal-Directed Therapy Collaborative Group. (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. New England Journal of Medicine, 345, 1368-1377.
34. Rubenfeld, G.D. & Crawford, S.W. (1996) Withdrawing life support from mechanically ventilated recipients of bone marrow transplants: a case for evidence-based guidelines. Annals of Internal Medicine, 125, 625-633.
35. Scales, D.C., Thiruchelvam, D., Kiss, A., Sibbald, W.J. & Redelmeier, D.A. (2008) Intensive care outcomes in bone marrow transplant recipients: a population-based cohort analysis. Critical Care, 12, R77.
36. Soubani, A.O., Kseibi, E., Bander, J.J., Klein, J.L., Khanchandani, G., Ahmed, H.P. & Guzman, J.A. (2004) Outcome and prognostic factors of hematopoietic stem cell transplantation recipients admitted to a medical ICU. Chest, 126, 1604-1611.
37. Thomson, K.J., Morris, E.C., Milligan, D., Parker, A.N., Hunter, A.E., Cook, G., Bloor, A.J., Clark, F., Kazmi, M., Linch, D.C., Chakraverty, R., Peggs, K.S. & Mackinnon, S. (2010) T-cell-depleted reduced-intensity transplantation followed by donor leukocyte infusions to promote graft-versus-lymphoma activity results in excellent long-term survival in patients with multiply relapsed follicular lymphoma. Journal of Clinical Oncology, 28, 3695-3700.